AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Arrowhead Pharmaceuticals, Inc.

$59.90 -$7.89 (-11.64%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$60.49
Day Range
$58.74$61.50
Year Range
$37.06$95.49
Market Cap
8.46B
AVG Volume
2.07M
Trailing/Forward PE
-26.74/-
PEG ratio
-0.71
Dividend Yield
-
Next Earnings Date
2026-11-24
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0500M1B1.5B24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARWR Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q3669.5M
26 Q2622.01M
26 Q11.09B
25 Q4829.45M
25 Q3572.98M
25 Q2545.21M
25 Q12.5M
24 Q43.55M
24 Q319.65M
24 Q235.47M
Net Income (USD) · TTM
-750M-500M-250M0250M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARWR Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q3-319.95M
26 Q2-300.91M
26 Q1202.26M
25 Q4-1.63M
25 Q3-148.42M
25 Q2-143.97M
25 Q1-639.71M
24 Q4-599.49M
24 Q3-538.64M
24 Q2-470.79M
Operating Income (USD) · TTM
-750M-500M-250M0250M500M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
ARWR Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q3-226.44M
26 Q2-221.9M
26 Q1300.57M
25 Q498.35M
25 Q3-107.96M
25 Q2-118.55M
25 Q1-625.95M
24 Q4-601.08M
24 Q3-547.21M
24 Q2-473.77M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ARWR

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 24 Nov 2026.

Arrowhead Pharmaceuticals, Inc.
ARWR
Stockpicker

Video analysis: ARWR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ARWR

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.